Either you're fortunate to have insurance, or you pay thousands per month in cash.
In the wake of a cultural hunger for weight loss solutions, a shadow market has grown around semaglutide — one of the most sought-after drugs of our era. A study published in JAMA Network Open reveals that nearly half of online pharmacies selling the drug operate outside the law, preying on people priced out of legitimate access by costs reaching $1,300 a month and insurance systems that routinely refuse coverage. What emerges is a familiar human story: where desperation meets scarcity, predation follows — and the body pays the price.
- Demand for semaglutide has outpaced both supply and affordability, pushing millions of Americans toward unregulated corners of the internet in search of a drug their doctors may recommend but their wallets cannot reach.
- Researchers found that half of the online orders they placed never arrived — replaced instead by escalating demands for hundreds of dollars more, classic scam architecture dressed in pharmaceutical clothing.
- The products that did arrive were not safe: one vial carried dangerous bacterial toxins, another contained nearly 40% more of the active drug than labeled — a silent overdose waiting to happen.
- Poison control centers logged nearly 3,000 semaglutide-related calls in under a year, a fifteenfold surge since 2019, most tied to dosing errors made by people navigating vials without medical guidance.
- Regulators have issued warnings and manufacturers have published fraud alerts, but the structural conditions — high prices, insurance exclusions, and persistent shortages — continue to feed the shadow market faster than enforcement can contain it.
The extraordinary demand for semaglutide, the active ingredient in Wegovy, has quietly spawned a dangerous parallel marketplace. A study published in JAMA Network Open examined six online pharmacies selling the drug and found that roughly four in ten such operations lack any legal license — taking payment for medications that never arrive, or shipping products laced with bacterial contamination and dangerous dosing errors.
The conditions driving people there are real. More than 2.5 million prescriptions were filled in the U.S. by December 2023, yet the drug costs up to $1,300 a month out of pocket, insurance coverage is routinely denied, and Medicare explicitly excludes it for weight loss. Manufacturers cannot keep pace with demand. Millions turn to the internet.
What researchers found there was predatory. Three of six test orders never arrived — websites instead demanded additional payments of $650 to $1,200 to supposedly clear customs. Of the three that did arrive, one contained dangerous endotoxin levels, another held nearly 40% more semaglutide than labeled — enough to cause severe nausea, blood sugar crashes, and fainting. Poison control centers fielded nearly 3,000 semaglutide-related calls between January and November 2023, a fifteenfold increase since 2019, most involving dosing errors from manual vials rather than the pre-measured pens that come with legitimate prescriptions.
Compounding pharmacies occupy a legal gray zone — permitted to mix medications without prescriptions when a drug appears on the FDA shortage list — but hospitalizations from compounded semaglutide overdoses have already occurred. Two of the six pharmacies tested had received FDA warning letters in the prior year.
The underlying issue, physicians note, is that GLP-1 drugs are not simple transactions. They carry significant side effects, require ongoing monitoring for kidney disease, depression, and other conditions, and can trigger eating disorders in vulnerable patients. None of that oversight exists when someone buys from an unlicensed site. As one weight loss clinic director observed: if a pharmacy asks nothing about who you are, it is not legitimate. For now, there are no safe shortcuts — only the steep price of access, or the steeper price of what lies beyond it.
The weight loss drug boom has created a dangerous shadow market. Researchers testing online pharmacies that sell semaglutide—the active ingredient in Novo Nordisk's Wegovy—found that roughly four in ten operate without any legal license, taking money for medications they never deliver or selling products contaminated with bacterial toxins and wildly incorrect doses. The study, published Friday in JAMA Network Open, examined six online pharmacies and discovered a landscape where desperation meets predation.
Semaglutide has become a cultural phenomenon. More than 2.5 million prescriptions were filled in the United States by December 2023 alone. The drug works, people want it, and the price—up to $1,300 a month out of pocket—puts it beyond reach for many. Insurance companies often refuse to cover it for weight loss, even though Medicare explicitly excludes it from coverage for that purpose. Most state Medicaid programs severely restrict access. The result is a supply crisis that manufacturers cannot solve, and millions of people turning to the internet.
What they find there is often not what they think. Three of the six orders placed by researchers never arrived. Instead, the websites demanded additional payments of $650 to $1,200, claiming the products needed to "clear customs." These were pure scams—money taken, nothing delivered. Of the three orders that did arrive, one vial contained dangerously high levels of endotoxin, a bacterial toxin that can make people severely ill when injected. Another sample contained 39 percent more semaglutide than the label indicated, a dosing error that could trigger overdose: severe nausea, vomiting, dangerous drops in blood sugar, fainting.
The human toll is already visible. From January through November 2023, poison control centers across the United States fielded nearly 3,000 calls related to semaglutide—a more than fifteenfold increase since 2019. Most involved dosing errors made by people injecting themselves with liquid from vials, which require manual measurement, rather than the pre-filled injection pens that come with legitimate prescriptions. The brand-name versions are designed to be foolproof. The counterfeit and compounded alternatives are not.
Two of the six pharmacies tested had already received warning letters from the Food and Drug Administration within the previous year for selling unapproved and misbranded semaglutide. Novo Nordisk has published guidance on spotting fakes—look for spelling errors on packaging, unsealed boxes, prices that seem impossible—but the company also notes that it is the only manufacturer in the United States producing FDA-approved semaglutide. Everything else is either counterfeit or compounded from unverified sources.
Compounding pharmacies occupy a gray zone. These are legitimate businesses that mix medications to meet individual patient needs, and they do not require prescriptions under normal circumstances when a drug appears on the FDA's shortage list—which several Wegovy dosages currently do. But the FDA warns that compounded drugs should only be used when no approved alternative exists, and that warning carries weight: people have been hospitalized after accidentally overdosing on compounded semaglutide due to dosing errors.
The deeper problem is that taking a GLP-1 drug is not a simple transaction. It requires medical judgment. These medications cause significant side effects—nausea, diarrhea, vomiting, constipation, headache, fatigue—and many people stop taking them after two years. The FDA advises doctors to monitor patients for kidney disease, eye disease, depression, and suicidal thoughts. Some physicians have observed that these drugs can trigger eating disorders in vulnerable patients. None of this monitoring happens when someone buys from an illegal online pharmacy. There is no doctor, no consultation, no understanding of the person's health history.
As one weight loss clinic director put it: if a pharmacy doesn't require a prescription, a medical consultation, or any knowledge of who you are, it is not legitimate. Right now, he said, there are no safe shortcuts. Either you have insurance coverage, or you pay thousands of dollars a month in cash. Everything else is a minefield.
Citas Notables
The average person cannot be expected to safely navigate this online medication minefield.— Dr. Christopher McGowan, founder of True You Weight Loss
In the best-case scenario, consumers just lose their money. In the worst scenario, you end up with medications that are potentially harmful.— Shabbir Safdar, executive director of the Partnership for Safe Medicines
La Conversación del Hearth Otra perspectiva de la historia
Why are so many people willing to take this risk? The dangers seem obvious.
Because the alternative is not taking the drug at all. When insurance won't cover it and you can't afford $1,300 a month, an illegal pharmacy starts to look like your only option.
But they're getting scammed. Money disappearing, fake products arriving. How do people not know?
The websites look professional. They have customer service emails. They ask for prescriptions sometimes, which makes them seem legitimate. By the time you realize you've been taken, your money is gone.
What about the people who do receive something? The contaminated vials, the overdoses?
They don't know what they're injecting. They're measuring doses from a liquid vial instead of using a pre-filled pen. One mistake in measurement and you're in an ambulance.
Is there any way to make this safer?
Not really. The safety comes from the entire system—the prescription, the doctor's judgment, the monitoring, the pre-measured doses. Strip all that away and you're left with just the drug and a person guessing.